TERIPARATIDE VERSUS ALENDRONATE FOR TREATING GLUCOCORTICOID-INDUCED OSTEOPOROSIS: 36-MONTH RESULTS

被引：0
|
作者：
Devogelaer, J. -P. [1 ]
Warner, M. [2 ]
Saag, K. [3 ]
Zanchetta, J. [4 ]
Adler, R. [5 ]
Eastell, R. [6 ]
See, K. [2 ]
Dalsky, G. [2 ]
Krohn, K. [2 ]
Krege, J. [2 ]
机构：
[1] St Luc Univ Hosp, Arthritis Unit, Brussels, Belgium
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] Univ Alabama, Birmingham, AL USA
[4] IDIM, Buenos Aires, DF, Argentina
[5] McGuire VA Med Ctr, Richmond, VA USA
[6] Univ Sheffield, Acad Unit Bone Metab, Sheffield, S Yorkshire, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [21] Teriparatide in the treatment of glucocorticoid-induced osteoporosis
    Bilezikian, J. P.
    BONE, 2009, 45 : S131 - S131
  • [22] Teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPS trial
    Glueer, C. C.
    Marin, F.
    Ringe, J. D.
    Hawkins, F.
    Moericke, R.
    Papaioannu, N.
    Farahmand, P.
    Minisola, S.
    Martinez, G.
    Nolla, J. M.
    Niedhart, C.
    Guanabens, N.
    Nuti, R.
    Martin-Mola, E.
    Thomasius, F.
    Kapetanos, G.
    Pena, J.
    Graeff, C.
    Petto, H.
    Sanz, B.
    Reisinger, A.
    Zysset, P.
    BONE, 2012, 50 : S40 - S41
  • [23] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Lems, Willem F.
    Laan, Roland F. J.
    Algra, Ale
    Huisman, Anne-Margriet
    Buskens, Erik
    de laet, Chris E. D.
    Oostveen, Ans C. M.
    Geusens, Piet P. M. M.
    Bruyn, George A. W.
    Dijkmans, Ben A. C.
    Bijlsma, Johannes W. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 675 - 684
  • [24] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    Minisola, Salvatore
    Scillitani, Alfredo
    Romagnoli, Elisabetta
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2156 - 2157
  • [25] Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
    Lau, Arthur N.
    Adachi, Jonathan D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 497 - 503
  • [26] Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
    Saag, KG
    Emkey, R
    Schnitzer, TJ
    Brown, JP
    Hawkins, F
    Goemaere, S
    Thamsborg, G
    Liberman, UA
    Delmas, PD
    Malice, MP
    Czachur, M
    Daifotis, AG
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05): : 292 - 299
  • [27] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis - Reply
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Bijlsma, Johannes W. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2157 - 2157
  • [28] Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Recknor, Chris
    See, Kyoungah
    Warner, Margaret R.
    Wong, Mayme
    Krohn, Kelly
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 141 - 148
  • [29] Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial
    Glueer, Claus-C
    Marin, Fernando
    Ringe, Johann D.
    Hawkins, Federico
    Moericke, Ruediger
    Papaioannu, Nikolaos
    Farahmand, Parvis
    Minisola, Salvatore
    Martinez, Guillermo
    Nolla, Joan M.
    Niedhart, Christopher
    Guanabens, Nuria
    Nuti, Ranuccio
    Martin-Mola, Emilio
    Thomasius, Friederike
    Kapetanos, Georgios
    Pena, Jaime
    Graeff, Christian
    Petto, Helmut
    Sanz, Beatriz
    Reisinger, Andreas
    Zysset, Philippe K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (06) : 1355 - 1368
  • [30] EXPERIENCE ON THE USE OF TERIPARATIDE FOR TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Saparbayeva, M.
    Issayeva, B.
    Issayeva, S.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S377 - S378
12345